Michael W. Bonney

Michael W. Bonney

DirectoratAlnylam Pharmaceuticals· In proxies 2023–2025

Michael W. Bonney sits on 8 public boards.

Boards1

  • Alnylam PharmaceuticalsDirector · 9 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Alnylam PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role 0%
  2. The American FundsPublic company
    • Director? – PresentNo stock prices for these years
  3. Bristol-Myers Squibb CompanyPublic company
    • Director? – PresentNo stock prices for these years
  4. Celgene CorporationPublic company
    • Director? – PresentNo stock prices for these years
  5. Magenta Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Pacira BioSciences, IncPublic company
    • Director? – PresentNo stock prices for these years
  7. Sarepta Therapeutics, IncPublic company
    • Director? – PresentNo stock prices for these years
  8. Syros Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?